TransMedics Group Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -141.4% | – | -73.3% | +186.8% | -114.5% | – | -24.1% | -50.4% | -28.9% | -29.4% | – | |
| – | +95.7% | +18.8% | +4.5% | +12.6% | +9.7% | +8.0% | +9.7% | +1.8% | +9.0% | +58.9% | -13.7% | – | |
| – | +10.3% | +20.0% | +11.3% | +3.9% | +35.5% | -16.8% | +4.6% | -2.5% | +2.8% | +5.9% | -13.5% | – | |
| – | – | – | – | -6,455.4% | – | – | – | -30.5% | -117.7% | – | – | – | |
| – | -61.2% | +5.6% | -46.2% | +102.8% | -71.8% | +98.7% | -66.4% | -16.0% | +103.5% | +136.3% | -80.7% | – | |
| – | -72.1% | +5.6% | -46.2% | +101.0% | -71.5% | +98.7% | -66.4% | -16.0% | +103.5% | +136.3% | -80.7% | – | |
| – | – | +11.7% | – | – | – | – | – | +52.6% | – | – | -102.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -39.3% | +244.7% | +234.1% | -26.1% | -84.9% | +155.3% | +134.1% | -48.6% | -14.9% | +21.4% | -74.2% | – | |
| – | – | – | – | -360.5% | – | -504.3% | – | -27.5% | -66.2% | -139.2% | – | – | |
| – | – | – | – | -2,214.9% | – | -593.5% | – | -24.9% | -69.3% | -163.8% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.